Patents by Inventor Monette Aujay

Monette Aujay has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL ANTI-TNFRSF21 ANTIBODIES AND METHODS OF USE
    Publication number: 20190127476
    Abstract: Provided are novel anti-TNFRSF21 antibodies and antibody drug conjugates, and methods of using such anti-TNFRSF21 antibodies and antibody drug conjugates to treat cancer.
    Type: Application
    Filed: May 5, 2017
    Publication date: May 2, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: LAURA SAUNDERS, DEEPTI ROKKAM, DAVID LIU, MANDY BOONTANRART, ALEXANDER JOHN BANKOVICH, EVAN BISHOP, MONETTE AUJAY, ZHAO HUANG
  • NOVEL ANTI-CLAUDIN ANTIBODIES AND METHODS OF USE
    Publication number: 20190077876
    Abstract: Provided herein are novel anti-CLDN antibodies and antibody drug conjugates (ADC), including derivatives thereof, and methods of using the same to treat proliferative disorders.
    Type: Application
    Filed: August 20, 2018
    Publication date: March 14, 2019
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: Marianne SANTAGUIDA, Monette AUJAY, Laura SAUNDERS, David LIU, Orit FOORD, Robert A. STULL, Paul Anthony ESCARPE
  • Anti-CD324 monoclonal antibodies and uses thereof
    Patent number: 10087258
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: November 16, 2016
    Date of Patent: October 2, 2018
    Assignee: AbbVie Stemcentrx LLC
    Inventors: Robert A. Stull, Monette Aujay, Orit Foord, Alex Bankovich, Johannes Hampl, Scott J. Dylla, David Liu
  • Anti-claudin antibodies and methods of use
    Patent number: 10053511
    Abstract: Provided herein are anti-CLDN antibodies and antibody drug conjugates (ADC), including derivatives thereof, and methods of using the same to treat proliferative disorders.
    Type: Grant
    Filed: November 5, 2014
    Date of Patent: August 21, 2018
    Assignee: AbbVie Stemcentrx LLC
    Inventors: Marianne Santaguida, Monette Aujay, Laura Saunders, David Liu, Orit Foord, Robert A. Stull, Paul Anthony Escarpe
  • ANTI-CD324 MONOCLONAL ANTIBODIES AND USES THEREOF
    Publication number: 20170121416
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: November 16, 2016
    Publication date: May 4, 2017
    Applicant: ABBVIE STEMCENTRX LLC
    Inventors: Robert A. STULL, Monette AUJAY, Orit FOORD, Alex BANKOVICH, Johannes HAMPL, Scott J. DYLLA, David LIU
  • NOVEL ANTI-RNF43 ANTIBODIES AND METHODS OF USE
    Publication number: 20170073430
    Abstract: The invention discloses novel anti-RNF43 antibodies and derivatives thereof, including antibody drug conjugates, and methods of using such anti-RNF43 antibodies and antibody drug conjugates to diagnose and treat cancer.
    Type: Application
    Filed: April 21, 2015
    Publication date: March 16, 2017
    Applicant: AbbVie Stemcentrx LLC
    Inventors: MANDY BOONTANRART, DEEPTI ROKKAM, DAVID LIU, SCOTT J. DYLLA, MONETTE AUJAY
  • Anti-CD324 monoclonal antibodies and uses thereof
    Patent number: 9534058
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Grant
    Filed: February 8, 2013
    Date of Patent: January 3, 2017
    Assignee: ABBVIE STEMCENTRX LLC
    Inventors: Robert A. Stull, Monette Aujay, Orit Foord, Alex Bankovich, Johannes Hampl, Scott J. Dylla, David Liu
  • NOVEL ANTI-CLAUDIN ANTIBODIES AND METHODS OF USE
    Publication number: 20160289332
    Abstract: Provided herein are novel anti-CLDN antibodies and antibody drug conjugates (ADC), including derivatives thereof, and methods of using the same to treat proliferative disorders.
    Type: Application
    Filed: November 5, 2014
    Publication date: October 6, 2016
    Applicant: Stemcentrx, Inc.
    Inventors: Marianne SANTAGUIDA, Monette AUJAY, Laura SAUNDERS, David LIU, Orit FOORD, Robert A. STULL, Paul Anthony ESCARPE
  • ANTI-CD324 MONOCLONAL ANTIBODIES AND USES THEREOF
    Publication number: 20150337048
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: February 8, 2013
    Publication date: November 26, 2015
    Inventors: Robert A. STULL, Monette AUJAY, Orit FOORD, Alex BANKOVICH, Johannes HAMPL, Scott J. DYLLA, David LIU
  • NOTUM PROTEIN MODULATORS AND METHODS OF USE
    Publication number: 20150322166
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat hyperproliferative disorders are provided.
    Type: Application
    Filed: May 6, 2015
    Publication date: November 12, 2015
    Applicant: STEM CENTRX, INC.
    Inventors: Robert A. STULL, Scott J. DYLLA, Orit FOORD, Monette AUJAY
  • Substrate for Rpn 11 enzymatic activity
    Patent number: 8697837
    Abstract: The present application provides peptides that serve as substrates for proteasome enzymatic activity, e.g., the enzymatic activity of Rpn11, a metalloprotease of the 19S regulatory particle. The present application also provides methods and compositions employing the peptide substrates.
    Type: Grant
    Filed: July 20, 2009
    Date of Patent: April 15, 2014
    Assignee: Onyx Therapeutics, Inc.
    Inventors: Francesco Parlati, Monette Aujay, Mark K. Bennett
  • NOTUM PROTEIN MODULATORS AND METHODS OF USE
    Publication number: 20130224191
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat hyperproliferative disorders are provided.
    Type: Application
    Filed: August 26, 2011
    Publication date: August 29, 2013
    Inventors: Robert A. Stull, Scott J. Dylla, Orit Foord, Monette Aujay
  • Novel Modulators and Methods of Use
    Publication number: 20130058947
    Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
    Type: Application
    Filed: February 8, 2012
    Publication date: March 7, 2013
    Inventors: Robert A. Stull, Monette Aujay, Orit Foord, Alex Bankovich, Johannes Hampl, Scott J. Dylla
  • NOVEL SUBSTRATE FOR RPN 11 ENZYMATIC ACTIVITY
    Publication number: 20100196346
    Abstract: The present application provides peptides that serve as substrates for proteasome enzymatic activity, e.g., the enzymatic activity of Rpn11, a metalloprotease of the 19S regulatory particle. The present application also provides methods and compositions employing the peptide substrates.
    Type: Application
    Filed: July 20, 2009
    Publication date: August 5, 2010
    Applicant: Proteolix, Inc.
    Inventors: Francesco Parlati, Monette Aujay, Mark K. Bennett
  • Substrate for Rpn11 enzymatic activity
    Patent number: 7741432
    Abstract: The present application provides peptides that serve as substrates for proteasome enzymatic activity, e.g., the enzymatic activity of Rpn11, a metalloprotease of the 19S regulatory particle. The present application also provides methods and compositions employing the peptide substrates.
    Type: Grant
    Filed: May 30, 2006
    Date of Patent: June 22, 2010
    Assignee: Proteolix, Inc.
    Inventors: Francesco Parlati, Monette Aujay, Mark K. Bennett
  • Novel substrate for Rpn11 enzymatic activity
    Publication number: 20060280731
    Abstract: The present application provides peptides that serve as substrates for proteasome enzymatic activity, e.g., the enzymatic activity of Rpn11, a metalloprotease of the 19S regulatory particle. The present application also provides methods and compositions employing the peptide substrates.
    Type: Application
    Filed: May 30, 2006
    Publication date: December 14, 2006
    Applicant: Proteolix, Inc.
    Inventors: Francesco Parlati, Monette Aujay, Mark Bennett